Position in XGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,441,890
-$625,452 QoQ
Shares Held
310,084
-55.0% QoQ
Ownership
1.28%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 57 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ACADIAN ASSET MANAGEMENT LLC holds $231,101,828 across 22 Diagnostics & Research names. XGN ranks #11 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DGX |
Quest Diagnostics Inc
|
346,489 | $73,438,343 | |
| 2 | MTD |
Mettler Toledo International Inc/
|
51,387 | $65,647,406 | |
| 3 | CSTL |
Castle Biosciences Inc
|
918,668 | $21,910,231 | |
| 4 | FLGT |
Fulgent Genetics, Inc.
|
1,017,913 | $20,887,574 | |
| 5 | MYGN |
Myriad Genetics Inc
|
3,126,973 | $17,855,015 | |
| 6 | QGEN |
Qiagen N.V.
|
233,416 | $9,126,565 | |
| 7 | GH |
Guardant Health, Inc.
|
38,450 | $5,768,653 | |
| 8 | CDNA |
CareDx, Inc.
|
186,391 | $5,312,143 |
All Filings in XGN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,441,890 | 310,084 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $2,067,342 | 689,114 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $2,519,843 | 414,448 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $1,250,991 | 113,830 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $87,941 | 12,599 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $25,072 | 6,984 | Shares | Defined | 2025-05-21 | |
| No filing history on record for this holder in this stock. | ||||||